S&P MERVAL Index Ends 3.78% Higher at 1576628.35 — Data Talk
The S&P MERVAL Index is up 57419.24 points or 3.78% today to 1576628.35
--Largest one-day point and percentage gain since Thursday, May 30, 2024
--Up for two consecutive trading days
--Up 72900.03 points or 4.85% over the last two trading days
--Largest two-day point and percentage gain since Friday, May 31, 2024
--Off 4.98% from its record close of 1659247.61 hit Monday, June 3, 2024
--Today's closing value is the sixth highest this year
--Off 4.98% from its 52-week high of 1659247.61 hit Monday, June 3, 2024
--Up 316.33% from its 52-week low of 378695.36 hit Wednesday, June 14, 2023
--Rose 313.08% from 52 weeks ago
--Off 4.98% from its 2024 closing high of 1659247.61 hit Monday, June 3, 2024
--Up 69.45% from its 2024 closing low of 930419.67 hit Tuesday, Jan. 2, 2024
--Month-to-date it is down 4.53%
--Year-to-date it is up 646924.16 points or 69.58%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 10, 2024 17:25 ET (21:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks